Dravet Syndrome
📧 Sign up to get email alerts when something new happens for Dravet Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome [Phase 3]
Phase 3 clinical trial evaluating safety, tolerability, and pharmacokinetics of fenfluramine in infants aged 1 to less than 2 years with Dra…
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome [Phase 3]
A Phase 3 trial evaluating safety, tolerability, and pharmacokinetics of fenfluramine hydrochloride in infants aged 1 year to less than 2 ye…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome [Phase 3]
Phase 3 trial evaluating soticlestat as add-on therapy in children and adults with Dravet syndrome or Lennox-Gastaut syndrome has terminated…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study of Soticlestat in Adults and Children With Rare Epilepsies [Phase 2]
Takeda reports termination of a Phase 2 study of Soticlestat in adults and children with rare epilepsies, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy [Phase 2]
This report covers a long-term, open-label Phase 2 safety study of LP352 in developmental and epileptic encephalopathy, including Dravet and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome [Phase 3]
Phase 3 study update reporting long-term safety data for ZX008 (fenfluramine hydrochloride) oral solution in children and adults with epilep…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures [Phase 3]
A Phase 3 study of adjunctive cannabidiol oral solution GWP42003-P in children with tuberous sclerosis complex, Dravet syndrome, or Lennox-G…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome [Phase 3]
A Phase 3 study of Soticlestat as add-on therapy for children and adults with Dravet syndrome or Lennox-Gastaut syndrome has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome [Phase 3]
Phase 3 study of lorcaserin as an adjunctive treatment for Dravet syndrome was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ) [Phase 1]
This Phase 1 trial evaluated the bioavailability of stiripentol after a single oral dose, comparing capsule administration to suspension in …
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine [Phase 3]
Phase 3 trial evaluating soticlestat in Dravet syndrome or Lennox-Gastaut syndrome patients with prior fenfluramine exposure was terminated;…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies
Clinical trial update describing an extended access program using lorcaserin to treat Dravet syndrome and other refractory epilepsies.
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome [Phase 3]
Phase 3 study evaluating soticlestat as add-on therapy in children and young adults with Dravet syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies [Phase 1, Phase 2]
Clinical trial update indicates LP352 has completed Phase 1/2 studies in developmental and epileptic encephalopathies. The program covers Dr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects. [Phase 1]
Phase 1 safety and pharmacokinetics data for oral EPX-100 in healthy subjects. The study supports continued development for Dravet Syndrome.
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA
A retrospective non-interventional study evaluating stiripentol use in Dravet syndrome patients in the United States has been completed.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome [Phase 3]
A Phase 3 trial evaluating the Embrace seizure detection watch in children and young adults with Dravet syndrome was terminated; results wer…
-
CLINICAL_TRIALS trial_result · 2023-09-25Clinical Trial Update: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome [Phase 3]
An open-label extension Phase 3 trial assessing the long-term safety of ZX008 (fenfluramine hydrochloride) oral solution in children and you…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome [Phase 2]
Phase 2 trial update for ataluren in nonsense mutation-related CDKL5 and Dravet syndrome (epilepsy) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Fenfluramine for Adult Dravet Patients [Phase 3]
Trial update for fenfluramine in adult Dravet patients is in Phase 3 with unclear status.
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome [Phase 3]
Phase 3 trial evaluating ZX008 (fenfluramine hydrochloride) oral solution as adjunctive therapy in children 2 years and older with Dravet sy…
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome [Phase 3]
Phase 3 trial of two fixed doses of fenfluramine (ZX008) in children and young adults with Dravet syndrome has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes [Phase 3]
Open-label extension study of cannabidiol (GWP42003-P) in children and adults with Dravet or Lennox-Gastaut syndromes completed; results pos…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy [Phase 1, Phase 2]
A terminated phase 1/2 clinical trial evaluating the effects of cannabidiol (CBD) on electrical and autonomic cardiac function in children w…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Verapamil as Therapy for Children and Young Adults With Dravet Syndrome [Phase 2]
Phase 2 trial investigating verapamil as therapy for children and young adults with Dravet syndrome has completed with results posted.